Get started
Author

John Aspegrén

Observed names: J. ASPEGRÉN, J. Aspegren, J. Aspegrén, J. C. Aspegrén, John Aspegren, John C Aspegrén
Observed institution: Orion Corporation (Finland)
ORCID: 0000-0003-3561-9391
Observed ORCID: 0000-0003-3561-9391
OpenAlex ID: A5004786708
Activity and safety of ODM-201 in patients with progressive metastatic castration-resistant prostate cancer (ARADES): an open-label phase 1 dose-escalation and randomised phase 2 dose expansion trial
2014 · Karim Fizazi, Christophe Massard, et al. · The Lancet Oncology · 201
Evaluation of the clinical efficacy and safety of dexmedetomidine or medetomidine in cats and their reversal with atipamezole
2006 · Mikael Granholm, Brett C McKusick, et al. · Veterinary Anaesthesia and Analgesia · 175
Evaluation of the clinical efficacy and safety of intramuscular and intravenous doses of dexmedetomidine and medetomidine in dogs and their reversal with atipamezole
2007 · M. Granholm, B. C. McKusick, et al. · Veterinary Record · 114
First-in-human Phase 1 open label study of the BET inhibitor ODM-207 in patients with selected solid tumours
2020 · Malaka Ameratunga, Irene Braña, et al. · British Journal of Cancer · 97
PDF
Clinical evaluation of the efficacy and safety of a constant rate infusion of dexmedetomidine for postoperative pain management in dogs
2009 · Chiara Valtolina, Joris H Robben, et al. · Veterinary Anaesthesia and Analgesia · 72
Dexmedetomidine constant rate infusion for 24 hours during and after propofol or isoflurane anaesthesia in dogs
2008 · Guan-Yu Lin, Joris H Robben, et al. · Veterinary Anaesthesia and Analgesia · 65
Pregabalin Alleviates Anxiety and Fear in Cats during Transportation and Veterinary Visits—A Clinical Field Study
2023 · Terttu Lamminen, Mira Korpivaara, et al. · Animals · 50
Randomized Placebo-Controlled Clinical Trial of a Chewable Formulation of Amlodipine for the Treatment of Hypertension in Client-Owned Cats
2015 · M. Huhtinen, G. Derré, et al. · Journal of Veterinary Internal Medicine · 48
Bioavailability of detomidine administered sublingually to horses as an oromucosal gel
2010 · H. KAUKINEN, J. ASPEGRÉN, et al. · Journal of Veterinary Pharmacology and Therapeutics · 40
Safety and Antitumour Activity of ODM-201 (BAY-1841788) in Chemotherapy-naïve and CYP17 Inhibitor-naïve Patients: Follow-up from the ARADES and ARAFOR Trials
2017 · Neal D. Shore, Teuvo L. Tammela, et al. · European Urology Focus · 33
PDF
Efficacy of a Single Dose of Pregabalin on Signs of Anxiety in Cats During Transportation—A Pilot Study
2021 · Terttu Lamminen, Mira Korpivaara, et al. · Frontiers in Veterinary Science · 29
PDF
Dexmedetomidine oromucosal gel reduces fear and anxiety in dogs during veterinary visits: A randomised, double‐blind, placebo‐controlled clinical pilot study
2021 · Mira Korpivaara, Mirja Huhtinen, et al. · Veterinary Record · 26
PDF
Safety and Antitumour Activity of ODM-201 (BAY-1841788) in Castration-resistant, CYP17 Inhibitor-naïve Prostate Cancer: Results from Extended Follow-up of the ARADES Trial
2017 · Karim Fizazi, Christophe Massard, et al. · European Urology Focus · 21
PDF
Bone Scan Index and Progression-free Survival Data for Progressive Metastatic Castration-resistant Prostate Cancer Patients Who Received ODM-201 in the ARADES Multicentre Study
2016 · Mariana Reza, Robert Jones, et al. · European Urology Focus · 15
PDF
Nanoparticle-based oral formulation can surprise you with inferior in vivo absorption in humans
2022 · Mayank Singhal, Elina Turunen, et al. · European Journal of Pharmaceutics and Biopharmaceutics · 7
Tasipimidine—the pharmacological profile of a novel orally active selective α2A-adrenoceptor agonist
2022 · Jyrki Lehtimäki, Niina Jalava, et al. · European Journal of Pharmacology · 7
Use of Detomidine Oromucosal Gel for Alleviation of Acute Anxiety and Fear in Horses: A Pilot Study
2020 · Francesca Dai, Julia Rausk, et al. · Frontiers in Veterinary Science · 7
PDF
Bone and soft tissue response from a phase I/II study with ODM-201 in metastatic castration-resistant prostate cancer (mCRPC).
2014 · Jorge A. Garcia, Vesa V Kataja, et al. · Journal of Clinical Oncology · 6
Safety and tolerability of long-term treatment with darolutamide in patients with metastatic castration-resistant prostate cancer
2023 · Robert Hugh Jones, Karim Fizazi, et al. · Prostate Cancer and Prostatic Diseases · 4
PDF
862 Safety and efficacy of ODM-201 in chemotherapy and CYP17-inhibitor naïve patients: Analysis of data from the ARADES and the ARAFOR trials
2014 · L. Tammela, C. Massard, et al. · European Urology Supplements · 4
Oromucosal dexmedetomidine gel for alleviation of fear and anxiety in dogs during minor veterinary or husbandry procedures.
2017 · M. Korpivaara, M. Huhtinen, et al. · CABI eBooks · 2
Long-term safety of darolutamide in patients with metastatic castration-resistant prostate cancer.
2022 · Egils Vjaters, Karim Fizazi, et al. · Journal of Clinical Oncology · 1
Oromucosal dexmedetomidine gel for alleviation of fear and anxiety in dogs during minor veterinary or husbandry procedures
2017 · Mira Korpivaara, John Aspegrén, et al. · British Small Animal Veterinary Association eBooks · 1
Long-term efficacy and safety of androgen receptor inhibitor ODM-201 in ARADES phase I/II trial.
2014 · Christophe Massard, Karim Fizazi, et al. · Journal of Clinical Oncology · 1
Mp27-13 Long-term Safety of Darolutamide Among Patients With Metastatic Castration-resistant Prostate Cancer Who Received More Than 4 Years of Therapy
2022 · Robert Hugh Jones, Karim Fizazi, et al. · The Journal of Urology
Works count: 31
Citation count: 1,026
H-index: 14
I10-index: 14
Year
Topic
Type